Literature DB >> 24653810

Prevalence and risk factors for hepatitis C and human immunodeficiency virus coinfection among children in enugu, Nigeria.

Jude Chijioke Eze1, Ngozi S Ibeziako2, Anthony N Ikefuna2, Ikenna C Nwokoye3, Nwachinaemere D Uleanya3, Gideon C Ilechukwu4.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) and Human Immunodeficiency virus (HIV), are major public health challenges in the developing world especially sub-Saharan Africa. The aim of this study was to determine the prevalence and risk factors of Hepatitis C virus infection among children infected with HIV.
METHODS: This was a cross-sectional study conducted at the Paediatric HIV Clinic, UNTH, Enugu between July and December 2009. Antibodies to HCV were analyzed by newer generation rapid chromatographic immunoassay method using the Chromatest one step HCV test kit. The data was analysed using the Statistical Package for Social Sciences (SPSS) version 15 statistical software. The chi squared test was used to test for significant association of categorical variables. A p-value of <0.05 was accepted as significant.
RESULTS: One hundred and eighteen children HIV-infected children, aged between eighteen months to fifteen years were included in the data analysis. Eight of the HIV infected subjects were positive for HCV, giving an HIV-HCV co-infection prevalence of 6.8%. Co-infection was more prevalent among males and in those in age group 11-15 years. Blood transfusion, irrespective of frequency (p<0.015), and injections for immunization (p<0.049) were the significant risk factors noted.
CONCLUSION: There is need for strengthening of existing preventive strategies against HCV and HIV infections such as screening of donor blood and safe injection practices in our locality.

Entities:  

Keywords:  Co-infection; Hepatitis C; Human immunodeficiency virus

Year:  2014        PMID: 24653810      PMCID: PMC3957207          DOI: 10.4314/ajid.v8i1.2

Source DB:  PubMed          Journal:  Afr J Infect Dis        ISSN: 2006-0165


  16 in total

Review 1.  Hepatitis C: the clinical spectrum of disease.

Authors:  J H Hoofnagle
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

2.  Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania.

Authors:  C Menendez; J M Sanchez-Tapias; E Kahigwa; H Mshinda; J Costa; J Vidal; C Acosta; X Lopez-Labrador; E Olmedo; M Navia; M Tanner; J Rodes; P L Alonso
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

3.  Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes.

Authors:  Simon M Agwale; Lorine Tanimoto; Chad Womack; Lillian Odama; Kimmy Leung; Dolores Duey; Ruth Negedu-Momoh; Israel Audu; Shehu B Mohammed; Uford Inyang; Barney Graham; Rainer Ziermann
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

4.  Human immunodeficiency virus and hepatitis C co-infection in sub-Saharan West Africa.

Authors:  C I Mboto; A Davies; M Fielder; A P Jewell
Journal:  Br J Biomed Sci       Date:  2006       Impact factor: 3.829

5.  Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS.

Authors:  O A Lesi; M O Kehinde; D N Oguh; C O Amira
Journal:  Niger Postgrad Med J       Date:  2007-06

6.  The global burden of disease attributable to contaminated injections given in health care settings.

Authors:  Anja M Hauri; Gregory L Armstrong; Yvan J F Hutin
Journal:  Int J STD AIDS       Date:  2004-01       Impact factor: 1.359

Review 7.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

Review 8.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

Review 9.  Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.

Authors:  Valsa Madhava; Christine Burgess; Ernest Drucker
Journal:  Lancet Infect Dis       Date:  2002-05       Impact factor: 25.071

10.  Genotypes of hepatitis C virus in Nigeria.

Authors:  A O Oni; T J Harrison
Journal:  J Med Virol       Date:  1996-07       Impact factor: 2.327

View more
  6 in total

1.  Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.

Authors:  Bayeh Abera; Yohanes Zenebe; Wondemagegn Mulu; Mulugeta Kibret; Getachew Kahsu
Journal:  BMC Res Notes       Date:  2014-11-25

2.  Seroprevalence and Correlates of Hepatitis C Virus Infection in Secondary School Children in Enugu, Nigeria.

Authors:  C B Eke; S O Ogbodo; O M Ukoha; V U Muoneke; R C Ibekwe; A N Ikefuna
Journal:  Ann Med Health Sci Res       Date:  2016 May-Jun

3.  Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda.

Authors:  Esperance Umumararungu; Fabien Ntaganda; John Kagira; Naomi Maina
Journal:  Biomed Res Int       Date:  2017-01-26       Impact factor: 3.411

Review 4.  Hepatitis C treatment: where are we now?

Authors:  Nicholas J Burstow; Zameer Mohamed; Asmaa I Gomaa; Mark W Sonderup; Nicola A Cook; Imam Waked; C Wendy Spearman; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2017-02-17

5.  Prevalence and risk factors for hepatitis c virus co-infection among human immunodeficiency virus-infected patients and effect of hepatitis c virus infection on acquired immunodeficiency syndrome cases at baseline.

Authors:  Abdulmumini Yakubu; Bello Hali; Abubakar Sadiq Maiyaki
Journal:  Ann Afr Med       Date:  2021 Oct-Dec

6.  Towards 2030 Target for Hepatitis B and C Viruses Elimination: Assessing the Validity of Predonation Rapid Diagnostic Tests versus Enzyme-linked Immunosorbent Assay in State Hospitals in Kaduna, Nigeria.

Authors:  Ismaila Nda Ibrahim; Aisha Indo Mamman; Muhammad Shakir Balogun; Aliyu Ahmadu Babadoko; Abdulaziz Hassan; Benjamin Augustine; Aisha Maude Suleiman; Ibrahim Usman Kusfa
Journal:  Niger Med J       Date:  2019 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.